As of 2025-12-18, the Relative Valuation of Rigel Pharmaceuticals Inc (RIGL) is 69.77 USD. This relative valuation is based on P/E multiples. With the latest stock price at 41.94 USD, the upside of Rigel Pharmaceuticals Inc based on Relative Valuation is 66.3%.
The range of the Relative Valuation is 24.00 - 128.84 USD.
| Range | Selected | |
| Trailing P/E multiples | 17.6x - 20.6x | 17.8x |
| Forward P/E multiples | 24.6x - 31.8x | 29.1x |
| Fair Price | 24.00 - 128.84 | 69.77 |
| Upside | -42.8% - 207.2% | 66.3% |
| Date | P/E |
| 2025-12-15 | 6.81 |
| 2025-12-12 | 6.53 |
| 2025-12-11 | 6.74 |
| 2025-12-10 | 6.60 |
| 2025-12-09 | 6.78 |
| 2025-12-08 | 6.95 |
| 2025-12-05 | 7.84 |
| 2025-12-04 | 7.59 |
| 2025-12-03 | 7.56 |
| 2025-12-02 | 7.11 |
| 2025-12-01 | 7.57 |
| 2025-11-28 | 8.09 |
| 2025-11-26 | 8.16 |
| 2025-11-25 | 7.94 |
| 2025-11-24 | 7.98 |
| 2025-11-21 | 7.40 |
| 2025-11-20 | 7.02 |
| 2025-11-19 | 6.68 |
| 2025-11-18 | 7.40 |
| 2025-11-17 | 6.81 |
| 2025-11-14 | 6.72 |
| 2025-11-13 | 6.39 |
| 2025-11-12 | 6.40 |
| 2025-11-11 | 6.08 |
| 2025-11-10 | 5.53 |
| 2025-11-07 | 5.64 |
| 2025-11-06 | 5.79 |
| 2025-11-05 | 6.06 |
| 2025-11-04 | 4.55 |
| 2025-11-03 | 4.91 |
| 2025-10-31 | 5.06 |
| 2025-10-30 | 5.07 |
| 2025-10-29 | 4.71 |
| 2025-10-28 | 4.76 |
| 2025-10-27 | 4.74 |
| 2025-10-24 | 4.80 |
| 2025-10-23 | 4.71 |
| 2025-10-22 | 4.92 |
| 2025-10-21 | 4.85 |
| 2025-10-20 | 4.72 |
| 2025-10-17 | 4.48 |
| 2025-10-16 | 4.50 |
| 2025-10-15 | 4.50 |
| 2025-10-14 | 4.39 |
| 2025-10-13 | 4.30 |
| 2025-10-10 | 4.51 |
| 2025-10-09 | 4.55 |
| 2025-10-08 | 4.61 |
| 2025-10-07 | 4.73 |
| 2025-10-06 | 4.63 |